NewAmsterdam Pharma EPS NAMS

Diluted earnings per share by quarter and over the last twelve months, from 2023.

NewAmsterdam Pharma's earnings per share was −$2.15 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.52.

Earnings per share over time

Fiscal year	EPS	Change
FY2025	−$1.72	n/a
FY2024	−$2.58	n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.52	n/a	−$2.15
Q1 FY26	Mar 31, 2026	−$0.40	n/a	−$1.78
Q4 FY25	Dec 31, 2025	−$0.62	n/a	−$1.72
Q3 FY25	Sep 30, 2025	−$0.61	n/a	−$2.03
Q2 FY25	Jun 30, 2025	−$0.15	n/a	−$1.60
Q1 FY25	Mar 31, 2025	−$0.34	n/a	−$1.86
Q4 FY24	Dec 31, 2024	−$0.93	n/a	−$2.58
Q3 FY24	Sep 30, 2024	−$0.18	n/a	n/a
Q2 FY24	Jun 30, 2024	−$0.41	n/a	n/a
Q1 FY24	Mar 31, 2024	−$1.06	n/a	n/a
Q3 FY23	Sep 30, 2023	−$0.57	n/a	n/a
Q2 FY23	Jun 30, 2023	−$0.47	n/a	n/a

Companies in Drug Manufacturers - General nearest NewAmsterdam Pharma's size, closest first, today.

Company	EPS, 12 months	Growth
NAMSNewAmsterdam Pharma	−$2.15
PBHPrestige Consumer Healthcare	$3.57	−16% a year
HRMYHarmony Biosciences	$3.09	−0% a year
NRIXNurix Therapeutics	$2.31
ANIPANI Pharmaceuticals	$4.70
PAHCPhibro Animal Health	$2.44	+107% a year
OGNOrganon	$0.77	−71% a year
ANABAnaptysbio	$4.57
LQDALiquidia	$1.39
PCRXPacira BioSciences	$0.35
ARQTArcutis Biotherapeutics	$0.22
Peer median	$2.38